Navigation Links
QBI neuroscientists make Alzheimer's disease advance
Date:6/10/2008

Queensland Brain Institute (QBI) neuroscientists at UQ have discovered a new way to reduce neuronal loss in the brain of a person with Alzheimer's disease.

Memory loss in people with Alzheimer's disease can be attributed to several factors.

These include a build-up of the neuro-toxin Amyloid beta the major component of amyloid plaques found in patients with Alzheimer's and corresponding degeneration of a specific population of nerve cells in the basal forebrain.

QBI neuroscientist Dr Elizabeth Coulson's research was recently published in the Journal of Neuroscience.

She said the research had established that the molecule known as p75 neurotrophin receptor was necessary for the Amyloid beta to cause nerve cell degeneration in the basal forebrain.

During her research, Dr Coulson's team found both in cultured cells and in an animal model of Alzheimer's disease that it was possible to completely prevent Amyloid beta toxicity by removing the p75 cell death receptor.

"Discovering how Amyloid beta triggers neuronal degeneration has been a question bugging neuroscientists for decades, and we have identified an important piece of the puzzle," Dr Coulson said.

These results provide a novel mechanism to explain the early and characteristic loss of brain cells that occurs in Alzheimer's disease which are known to be important for memory formation.

Dr Coulson already has patented molecules that can block p75 and is ready to begin testing them in animal models of Alzheimer's disease.

"If such therapy is successful, it probably wouldn't cure this multifaceted disease," Dr Coulson said.

"But it would be a significant improvement on what is currently available for Alzheimer's disease patients."

The World Health Organisation predicts that by 2040, neurodegenerative conditions will become the world's leading cause of death, overtaking cancer.

Alzheimer's disease is the most common dementia affecting 10 per cent of people over 65 and 40 per cent over 80 years of age.

Significant advances in determining the molecular regulation of nerve cell function and survival have major impact on our understanding of more complex areas such as behaviour, cognition, aging and neurological diseases.


'/>"/>

Contact: Dr. Elizabeth Coulson
communications@uq.edu.au
61-733-466-392
Research Australia
Source:Eurekalert

Related medicine news :

1. Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease
2. Jefferson neuroscientists find early lead exposure impedes recovery from brain injury
3. Alzheimers Research Target May Be a Dead End
4. Smoking may strongly increase long-term risk of eye disease
5. Pot bellies linked to early signs of cardiovascular disease
6. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
7. Radiologists encouraged to look beyond cancer for clinically unseen diseases
8. Use of certain lipid measures not more effective in predicting coronary heart disease
9. Role seen for cannabis in helping to alleviate allergic skin disease
10. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
11. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... Utah (PRWEB) , ... May 24, 2017 , ... ... Sick Kids: The Surprising Truth about Pediatric Septic Shock” hosted by the Journal of ... 2017, at 2 p.m. Eastern time, will be presented by Captain Rommie Duckworth, LP, ...
(Date:5/24/2017)... ... ... thinking of a visit to San Francisco , fall is a great time to ... , Business Architecture Associates is pleased to offer 5 days of training courses, available to ... for individuals, and as 4-½ day corporate package for up to 3 employees with the ...
(Date:5/24/2017)... ... ... Lowe is a sought after actor, and also serves as the host of the ... all aspects of life, and a new segment is being developed on podiatry, which ... is essential to people’s overall well-being, and if viewers have feet problems, they may ...
(Date:5/24/2017)... ... 24, 2017 , ... Fiberstar, Inc., http://www.FiberstarIngredients.com a ... beverage industry offers Citri-Fi®, a natural citrus fiber, to improve beverage ingredient declarations. ... a result, labels need to deliver simple, transparent and clear messaging. Listed food ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dymedix® Diagnostics, Inc., ... announced today it had completed the first phase of building a global distribution ... rest of world (ROW) authorized dealers specializing in polysomnography accessories. The company ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., has ... ("WRB"), a health care service center company based in ... specializes in relationship management programs for leading pharmaceutical manufacturers ... WRB will join Envoy Health Management, ... for manufacturers, biotech firms, and other service companies. Together, ...
(Date:5/4/2017)... -- Fortuna Fix Inc. (" Fortuna "), a private, clinical-stage ... the need for embryonic and fetal stem cells by using ... Fortuna announced today the launch of its ... MD, PhD; Father Kevin FitzGerald , S.J., PhD; Col. ... James Giordano , PhD. "We are excited and ...
(Date:5/4/2017)...  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... today announced that it is teaming up with Auto ... to lower diabetes healthcare costs in Canada ... is available throughout all provinces and territories in ... for additional savings when shopping for Dario supplies in ...
Breaking Medicine Technology: